文章基本信息

标题：An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
本地全文：下载
作者：Stephen I. Walimbwa ; Julian P. Kaboggoza ; Catriona Waitt 等
期刊名称：Trials
印刷版ISSN：1745-6215
电子版ISSN：1745-6215
出版年度：2021
卷号：22
DOI：10.1186/s13063-021-05752-1
语种：English
出版社：BioMed Central
摘要：Background Remdesivir is a novel broad-spectrum antiviral therapeutic with activity against several viruses that cause emerging infectious diseases. The purpose of this study is to explore how commonly utilized antiretroviral therapy (tenofovir disoproxil fumarate/lamivudine [TDF/3TC
关键词：Remdesivir; COVID-19; Ebola; HIV; Atazanavir; Ritonavir; Tenofovir; Lamivudine; Drug-drug interactions